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Abstract 
The prognosis of malignant peritoneal mesothelioma is extremely poor with a mean 
survival time of 12 months. The initial symptoms are poor and atypical. Because of its 
rare entity and little knowledge of its treatments, there are few reports of long-term 
survival. We encountered a very unique case with strong impression on radiological 
findings of malignant peritoneal methothelioma. We had misdiagnosed it because of the 
findings and because the time course was similar to that of ischemic colitis. The 
radiological findings on CT and enema disappeared within one week after antibiotic 
therapy. 
Introduction 
The prognosis of malignant peritoneal mesothelioma (MPM) is extremely poor with a 
mean survival time of 12 months. The initial symptoms are poor and atypical (abdominal 
distention, dull pain, ascites). The diagnosis can be confirmed by histopathological 
findings or hyaluronic acid level of ascites. It is hard to make a first diagnosis and most 
cases are found to show wide spread to other organs. Thus, the patients receive a 
diagnosis after collection of a huge amount ascites or surgical treatment. Because of its 
rare entity and little knowledge of its treatments, there are few reports of long-term 
survival. We experienced a case that achieved long-term survival with the combination 
regimen of CDDP + VP-16 followed by surgical resection. This regimen has a potential to 
improve survival.  
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Case Report 
A 74-year-old woman was admitted to a local clinic with lower abdominal pain, melena and 
low-grade fever. Contrast enema demonstrated segmental stenosis and a thumbprint-like appearance in 
the sigmoid colon (fig. 1a). Pelvic enhanced CT showed wall thickening and mesenterium inflammation 
of the sigmoid colon (fig. 1b). The patient was diagnosed with ischemic colitis. The radiological findings 
and inflammatory response improved within one week following antibiotic therapy (fig. 1c). Four 
month later, she was referred to our hospital because of waxing and waning abdominal symptoms. 
Laboratory data were not specific but for inflammatory response. The serum CA125 level had increased 
to 202 U/ml among other tumor markers. A 50-mm slightly enhanced oval tumor with a small amount 
of ascites was detected on pelvic CT (fig. 1d). Surgical treatment was performed with a diagnosis of 
gastrointestinal stromal tumor. 
At operation, a large volume of clear mucous ascites and a number of rice-grain-sized white 
disseminated lesions scattering in the Douglas pouch were noted. The 54-mm yellowish elastic soft 
tumor involved the mesentery of the small intestine and stretched and compressed to the serous 
membrane whereas the intestinal lumen was intact (fig. 2a). The tumor was suspected of being 
extraintestinal in origin and partial resection of small intestine was performed. Hematoxylin-eosin 
staining showed anisokaryosis and structural atypia (fig. 2b). CD34 and C-kit were negative while 
keratin, vimentin and EMA(+) were positive on immunohistochemistry. The diagnosis of MPM was 
settled by a marked elevated hyaluronic acid level of 625,000 ng/ml ascites sample. 
Combination chemotherapy of CDDP and VP-16 was performed as adjuvant chemotherapy. The 
patients has stably treated with this regimen once a month with no new lesions, no elevation of tumor 
markers and no ascites for 2 years. 
Discussion 
MPM is hard to diagnose preoperatively. The existence of thickness in the peritoneum 
and mesenterium, intraabdominal multiple nodules and ascites are not specific [1]. The 
peritoneal origin accounts for 12.5–25% in all malignant mesotheliomas [2] and is often 
found in patients in their 40s to 50s. Although a causal relationship with asbestos has been 
demonstrated, some have no exposure history like the present case [3]. It is histologically 
classified into epithelial (most common), sarcomatoid and biphasic types [4], but there is 
no therapeutic differentiation. There are few reports of long-term survival and the 
prognosis is extremely poor with a mean survival time of 12 months [5]. 
The hyaluronate acid level of ascites is the only way to make a differential diagnosis, 
however MPM is rarely considered as in the present case. Moreover, preoperative 
diagnosis is generally difficult because of the discrimination between reactive 
mesothelium cells and tumor cells. The immunohistological staining of hyaluronic acid 
by Alcian blue and hyaluronidase digestive test in tumor cells is definitive for diagnosis. 
CA125 level is not specific for this disease, but some reports propose that CA125 is useful 
as an indicator of treatment effects. 
Although surgical treatment is recommended for the MPM, complete resection is often 
difficult. Most cases show wide spread to other organs when surgical treatment is 
performed. In such cases, adjuvant therapies aree indispensable to prolong the prognosis 
while there are few reports of long-term survival [6, 7]. 
There has been no consensus of the effective treatments for MPM. We previously 
experienced two cases who achieved long-term ascitic control with combination 
chemotherapy of CDDP and VP-16 followed by surgical treatment [8]. This regimen has 
also good impact on survival in the present case. The patient already had multiple 
peritoneal disseminations at operation, however she remains alive over 2 years after  
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surgery without symptoms. The combination therapy of this regimen following reduction 
surgery may be a powerful option for MPM. 
 
 
 
 
 
Fig. 1. a Contrast enema demonstrated segmental stenosis and a thumbprint-like appearance in the 
sigmoid colon. b Pelvic enhanced CT showed wall thickening and mesenterium inflammation of the 
sigmoid colon. c The radiological findings on contrast enema had vanished within one week following 
antibiotic therapy. d An oval slightly enhanced tumor 50 mm in diameter was detected on pelvic CT. 
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Fig. 2. a Intraoperative photograph. The 54-mm yellowish elastic soft tumor involved the mesentery of 
the small intestine and stretched and compressed to the serous membrane whereas the intestinal lumen 
was intact. b Hematoxylin-eosin staining showed marked anisokaryosis and structural atypia. Original 
magnification ×400. 
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